Osteoarthritis Market is to rise at 6.8% CAGR by 2023, according to Global Osteoarthritis Market Information by Type (Hip Osteoarthritis, Spinal Osteoarthritis) By Diagnosis (Imaging, Joint Fluid Analysis) By Treatment (Medication, Surgery, Therapy) By End Users (Hospitals, Medical Institutes) and Region. The increasing cases of osteoarthritis in the elderly population are the main demand drivers for the Osteoarthritis market.
Osteoarthritis Market Key Players Analyzed for this report:
Novartis AG (Europe), Abbott. (U.S.), Merck Sharp & Dohme Corp. (U.S.), Eli Lilly and Company. (U.S.), ABIOGEN PHARMA S.p.A (Europe), Pfizer Inc. (U.S.), Ampio Pharmaceuticals Inc. (U.S.), Regeneron (U.S.), TissueGene Inc. (U.S.), and others.
Get Free Sample “Osteoarthritis Market Report 2019”at: https://www.marketresearchfuture.com/sample_request/1609
The rising geriatric and obese population are spurring the detection of osteoarthritis globally. Market reports connected with the healthcare industry have been made available by Market Research Future which generates reports on other business verticals that outlines the current market scenarios. The market is anticipated to develop at a 6.8% CAGR in the forecast period.
The market is expected to benefit from the augmented detection rates and improved accessibility to healthcare facilities where treatment can be sought. Increased investment in developing effective treatment options is anticipated to spur the osteoarthritis market’s growth in the forecast period.
The Osteoarthritis Market is segmented based on diagnosis, end users, type, and treatment.
Based on type, the osteoarthritis market is segmented into wrist osteoarthritis, spinal osteoarthritis, hip osteoarthritis, and others.
Based on diagnosis, the market is segmented into joint fluid analysis, imaging, and others. The imaging segment is additionally sub-segmented into X-rays, magnetic resonance imaging (MRI), and others.
Based on treatment, the market is segmented into surgery, therapy, medication, and others. The medication segment is sub-segmented into analgesics, non-steroidal anti-inflammatory drugs and others. The analgesics sub-segment, on the basis of medication, is further segmented into acetaminophen, duloxetine, and others. The non-steroidal anti-inflammatory drugs sub-segment, on the basis of medication, is further segmented into naproxen sodium, ibuprofen, naproxen, aspirin, and others.
Based on end users, the osteoarthritis market is segmented into hospitals & clinics, medical institutes, research organization, and others.
The regional analysis of the osteoarthritis market observes that the American region controls the osteoarthritis market due to a strong healthcare sector and strong patient population for osteoarthritis. Apart from these factors, the varying lifestyles and growing healthcare spending have increased the development of the market in the American region. The European region is the next major osteoarthritis market, which is trailed by the Asia Pacific region. The accessibility to funds for research, vast patient population, growing healthcare expenses, well-developed healthcare sector and government backing for research & development are anticipated to boost the market development during the forecast period. Eastern Europe is the fastest mounting region due to the vast opportunities in the unexploited market.
The Asia Pacific region is the fastest rising region in global market owing to the incidence of a vast patient population, constantly developing economies like India and China, and the existence of enormous opportunity in the market. Moreover, promising government policies and growing healthcare expenditures are fuelling the market development within the region. Conversely, the Middle East & African region controls the smallest portion in the osteoarthritis market globally owing to the incidence of a poor economy, particularly, in the African region. The Middle Eastern region holds a majority of the market of this region due to the strong healthcare sector and vast healthcare spending by countries like Saudi Arabia, Kuwait, Dubai, and Qatar.
List of Tables:
Table 1 Osteoarthritis Industry Synopsis, 2017 – 2023
Table 2 Global Osteoarthritis Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Global Osteoarthritis Market By Region, 2017 – 2023, (USD Million)
Table 4 Global Osteoarthritis Market By Type, 2017 – 2023, (USD Million)
Table 5 Global Osteoarthritis Market By Diagnosis, 2017 – 2023, (USD Million)
Table 6 Global Osteoarthritis Market By Treatment, 2017 – 2023, (USD Million)
Table 7 Global Osteoarthritis Market By End Users, 2017 – 2023, (USD Million)
Table 8 North America Osteoarthritis Market By Type, 2017 – 2023, (USD Million)
Table 9 North America Osteoarthritis Market By Diagnosis, 2017 – 2023, (USD Million)
List of Figures:
Figure 1 Research Process
Figure 2 Segmentation For Global Osteoarthritis Market
Figure 3 Market Dynamics For Global Osteoarthritis Market
Figure 4 Global Osteoarthritis Market Share, By Type 2016
Figure 5 Global Osteoarthritis Market Share, By Diagnosis 2016
Figure 6 Global Osteoarthritis Market Share, By Treatment, 2016
Figure 7 Global Osteoarthritis Market Share, By End Users, 2016
Figure 8 Global Osteoarthritis Market Share, By Region, 2016
Figure 9 North America Osteoarthritis Market Share, By Country, 2016
Figure 10 Europe Osteoarthritis Market Share, By Country, 2016
Figure 11 Asia Pacific Osteoarthritis Market Share, By Country, 2016
Figure 12 Middle East & Africa Osteoarthritis Market Share, By Country, 2016
Figure 13 Global Osteoarthritis Market: Company Share Analysis, 2016 (%)
Figure 14 Abbott.: Key Financials
Figure 15 Abbott.: Segmental Revenue
Figure 16 Abbott.: Geographical Revenue
Figure 17 Kinetec: Type UK Ltd: Key Financials
Browse More Information at: https://www.marketresearchfuture.com/reports/osteoarthritis-market-1609
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Phone: +1 646 845 9312